# mRNA Vaccine Urticaria Safety Analysis

**ID:** VAX-010
**Year:** 2025
**Source:** IAVI
**Link:** [https://www.eatg.org/hiv-news/dual-studies-reveal-early-successes-for-mrna-hiv-vaccine-strategies/](https://www.eatg.org/hiv-news/dual-studies-reveal-early-successes-for-mrna-hiv-vaccine-strategies/)

---

## Abstract

Safety analysis of urticaria reactions in mRNA HIV vaccine trials and mitigation strategies.

---

## Key Concepts

- Primary research focus from 2023-2025 HIV literature
- Relevant to understanding HIV biology, treatment, or prevention
- Contributes to the broader HIV research landscape

---

## Relevance to Project

This paper contributes to the Ternary VAE bioinformatics project by providing context on:
- HIV sequence evolution and variability
- Biological constraints on viral fitness
- Therapeutic targets and resistance mechanisms

---

*Added: 2025-12-24*
